The range and distribution of murine central nervous system cells infected with the gamma(1)34.5- mutant of herpes simplex virus 1.
about
A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunityViruses and autophagyTLR2 activation inhibits embryonic neural progenitor cell proliferationB-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cellsVirotherapy against malignant glioma stem cellsAttenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in miceMicroglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells.HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applicationsCell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1.Cancer stem cells: the final frontier for glioma virotherapy.Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.The Ebola virus VP35 protein functions as a type I IFN antagonist.Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements.Herpes simplex virus-based vectors.Transcription of the derepressed open reading frame P of herpes simplex virus 1 precludes the expression of the antisense gamma(1)34.5 gene and may account for the attenuation of the mutant virusThe herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34.Viral evasion of autophagy.Trial watch: Oncolytic viruses for cancer therapyToxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with ProdrugsAutophagy and viral neurovirulence.Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates.When autophagy meets viruses: a double-edged sword with functions in defense and offense.Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response.Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteinsUltrastructural analysis of ICP34.5- herpes simplex virus 1 replication in mouse brain cells in vivo.The γ134.5 Neurovirulence Gene of Herpes Simplex Virus 1 Modifies the Exosome Secretion Profile in Epithelial Cells.Questioning the Extreme Neurovirulence of Monkey B Virus (Macacine alphaherpesvirus 1).
P2860
Q27319470-E63AB5EE-B19C-41BE-9868-B2DF7DB994A2Q27491341-3800A78E-D6C9-4B5A-A6CF-3C28049E896CQ30495687-1ED9EEEB-67FA-4966-A1AA-F3395E989B38Q33649894-65B66A40-954B-4CB4-A61E-6FDCF2BFF89FQ33665530-A33930F6-48BB-414B-B78D-1D3F8C4194DBQ33802747-008912E9-8E42-4329-9EA4-11033C5498F5Q33934056-F1C67A0D-DB05-4FEA-8C64-FFFAE6630E83Q33995752-09BCB979-53BF-492D-B705-31904AE76F0FQ34341979-C4689ACE-77E0-402C-98AD-50807304AE09Q34516701-9DDC2C31-D587-4F49-814C-AFFC39A8CAB9Q35023819-A2FB852C-4DEC-4C70-B599-497BEC7F68B5Q35105093-E332C38C-B434-4515-9360-B8ED58ADAFE2Q35422223-2EE1CFB9-93D0-4DFA-9FE6-B2282D47B83AQ35635064-8574AEC9-A05E-491D-981F-2CACED1D9C56Q35863367-BD2A37EB-21E0-432B-9BB4-D5A48902CF04Q35895914-4B2A98C6-40D2-4C8B-AB09-FB71E9B2C1ECQ36548927-26EF0F5B-D32B-4313-B6B1-249A25084632Q37024346-48013B97-AE5F-408A-AD9F-D6B667CFE9FAQ37028023-258771D9-E5C0-4DC9-A65B-D1965B146F18Q37138701-73696B24-4F9D-4CCE-8365-BB83DE656B69Q37173279-EB843F55-3F53-4D52-9747-ED5661B21F31Q37596491-57EBC6E3-14EB-4E81-80EF-0010DACA7ADFQ37718569-D3EE6100-A0A5-4D86-9BEA-076663361A91Q37791919-67279939-55CE-4311-B85C-9FA2B8D6B7BCQ37945174-97A5C649-E136-4457-B154-1F97B09A6A1EQ38218674-6EF59216-A82C-4A41-A0D3-689A67C99E03Q39699288-CB9530D2-DC24-42F6-A6CD-9884556E10A8Q39848419-4A3233C2-8782-41CA-927D-03AD1F8A51F4Q42368523-19477234-3E8C-4407-8519-7CABB324FF17Q54233707-9C021776-7F06-4245-8C48-0E4EF4B99F6F
P2860
The range and distribution of murine central nervous system cells infected with the gamma(1)34.5- mutant of herpes simplex virus 1.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The range and distribution of ...... ant of herpes simplex virus 1.
@ast
The range and distribution of ...... ant of herpes simplex virus 1.
@en
type
label
The range and distribution of ...... ant of herpes simplex virus 1.
@ast
The range and distribution of ...... ant of herpes simplex virus 1.
@en
prefLabel
The range and distribution of ...... ant of herpes simplex virus 1.
@ast
The range and distribution of ...... ant of herpes simplex virus 1.
@en
P2860
P1433
P1476
The range and distribution of ...... tant of herpes simplex virus 1
@en
P2093
N S Markovitz
P2860
P304
P407
P577
1997-07-01T00:00:00Z